CJC 1295 vs MK 677: compare the injectable peptide and oral GH secretagogue. Learn how they differ in half-life, side effects, and legal status.
CJC-1295 is an injectable peptide that stimulates growth hormone release, while MK-677 is an oral compound that raises growth hormone and IGF-1 through a different receptor. The two are often compared because both target the growth hormone axis, but they differ in half-life, administration route, side effects, and legal status. Neither CJC-1295 nor MK-677 is FDA-approved for human use in the United States.
What Is CJC-1295?
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH). It comes in two main forms: CJC-1295 with DAC (drug affinity complex) and CJC-1295 without DAC, also called Mod GRF 1-29. The DAC form binds to albumin in the blood, extending its half-life to roughly 6-8 days. The non-DAC form has a much shorter half-life, often measured in minutes to a few hours.
Because CJC-1295 is a peptide, it must be injected. Researchers typically use subcutaneous injections. The cjc-1295 dac vs no dac distinction matters because the DAC version stays active much longer, which can lead to more sustained growth hormone elevation. CJC-1295 was originally developed for diagnostic use, but it is now sold as a research chemical.
What Is MK-677?
MK-677, also known as ibutamoren, is a non-peptide ghrelin receptor agonist. It mimics the hunger hormone ghrelin to stimulate growth hormone release from the pituitary gland. Unlike CJC-1295, MK-677 is taken orally and has a half-life of about 24 hours. It is not a peptide and is often sold as a research chemical.
MK-677 is popular in fitness circles because it is easier to take than injectable peptides. It was studied in the 1990s for conditions like frailty and growth hormone deficiency, but it was never approved for human use. Its long-term safety profile is unknown.
Key Differences Between CJC-1295 and MK-677
When researchers compare cjc-1295 vs mk-677, they often focus on half-life and route, but the differences go deeper. The table below summarizes the main distinctions.
| Feature | CJC-1295 | MK-677 |
|---|---|---|
| Chemical type | Peptide (GHRH analog) | Non-peptide (ghrelin agonist) |
| Administration | Subcutaneous injection | Oral capsule or liquid |
| Half-life | ~6-8 days (with DAC); minutes (without DAC) | ~24 hours |
| Mechanism | Binds GHRH receptors | Activates ghrelin receptors |
| FDA approval | Not approved for human use | Not approved for human use |
| Common side effects | Injection site reactions, flushing, headache | Increased appetite, water retention, fatigue, numbness |
One practical difference is control. CJC-1295 without DAC clears quickly, so researchers can adjust timing. CJC-1295 with DAC produces a steady, long-lasting rise in growth hormone. MK-677 is oral and convenient, but it can cause constant hunger and may affect blood sugar.
Another difference is that MK-677 raises IGF-1 levels more consistently in some studies, while CJC-1295's effect depends heavily on the DAC version.
Side Effects and Safety Considerations
Both compounds carry risks, and neither is approved for human use. Common side effects of CJC-1295 include injection site reactions, flushing, and headache. MK-677 is more often linked to increased appetite, water retention, fatigue, and numbness or tingling in the hands.
MK-677 may also reduce insulin sensitivity, which is a concern for people with diabetes or metabolic syndrome. CJC-1295 with DAC can cause prolonged growth hormone elevation, which may lead to joint pain and swelling. Some users report lethargy or carpal tunnel-like symptoms with both compounds. Long-term safety data for both compounds are lacking.
Anyone considering these compounds should talk to a healthcare professional. Self-experimentation with unapproved research chemicals carries unknown risks.
How People Choose Between Them
If you are comparing mk 677 vs cjc-1295, the choice often comes down to convenience versus control. MK-677 is oral and easy to use, but it has a higher chance of appetite and blood sugar side effects. CJC-1295 requires injections but may offer more predictable growth hormone release, especially the non-DAC form.
Some researchers also look at cjc 1295 ipamorelin vs mk 677 when considering stacked protocols. Ipamorelin is another peptide that stimulates growth hormone release, and it is sometimes combined with CJC-1295. For fat loss specifically, the aod-9604 vs cjc-1295 ipamorelin comparison addresses a different pathway because AOD-9604 is a fragment of growth hormone that targets fat metabolism.
Others compare cjc-1295 vs sermorelin to understand shorter-acting GHRH options. Sermorelin has a much shorter half-life than CJC-1295 with DAC, which may make it easier to control but less convenient.
Bottom Line
CJC-1295 is an injectable peptide that raises growth hormone for days, while MK-677 is an oral ghrelin agonist that raises growth hormone for about a day. Neither is FDA-approved for human use, and both have side effects that require medical supervision. The right choice depends on whether you prefer oral convenience or injectable control, but neither should be used without professional guidance.
Frequently Asked Questions
Is CJC-1295 or MK-677 better for muscle growth?
Neither CJC-1295 nor MK-677 is FDA-approved for human use, so there is no established 'better' option for muscle growth. Both can raise growth hormone and IGF-1, which may support muscle growth in research settings, but human data are limited. MK-677 is oral and easier to take, while CJC-1295 is injectable and may produce more sustained growth hormone elevation.
Can you stack CJC-1295 and MK-677 together?
Some researchers combine CJC-1295 and MK-677 because they work through different receptors. However, stacking increases the risk of side effects like water retention, increased appetite, and insulin resistance. There is no clinical safety data on combining these compounds in humans.
Are CJC-1295 and MK-677 legal to buy in the US?
Neither CJC-1295 nor MK-677 is approved by the FDA for human use. Both are sold as research chemicals, and it is illegal to sell them as dietary supplements. Possession and use may be restricted depending on state law and the context.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.